Clinical trial on the effects of dietary intake of sulforaphane-rich broccoli sprouts on severity of ulcerative colitis.

Clinical trial on the effects of dietary intake of sulforaphane-rich broccoli sprouts on severity of ulcerative colitis. - BS-UC-2020

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041972

Enrollment

Registered

2020-10-01

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Broccoli Sprouts (20 g/day, 8 weeks) Alfalfa Sprouts (20 g/day, 8 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age higher than 20 years. 2. Mild UC (Rachmilewits index less than 5) 3. Presence of maintenance therapy with mesalazine 4. Appropriate informed consent 5. Fecal Protectin level higher than upper limit of normal value

Exclusion criteria

Exclusion criteria: 1. Regular use of lactobacillus, steroids, immuno-modulators, biological drugs, caclineurin inhibitors, JAK kinase inhibitors. 2. Fecal Protectin level less than upper limit of normal value 3. Hospitalized Patients 4. Start of ASA treatment, or iIncrease in 5-ASA within 4 weeks 5. G-CAP or L-CAP treatment within 3 months 6. Treatment with herbal medicine including quingdao 7. Any other reasons judged by the principle investigator

Design outcomes

Primary

Measure	Time frame
Fecal calprotectin level (before and after 8 weeks treatment)	—

Countries

Japan

Contacts

Public ContactAkinori Yanaka

University of Tsukuba Hitachi Medical Education and Research Center

ynk-aki@md.tsukuba.ac.jp0294-23-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026